Multicell Technologies Stock

Multicell Technologies Equity Turnover

The Equity Turnover of Multicell Technologies (MCET) as of Aug 10, 2026 is -0.34.

Equity Turnover

-0.34

Last updated:

Equity Turnover of Multicell Technologies is 2026 -0.34 . Equity Turnover of Multicell Technologies was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Multicell Technologies Stock analysis

What does Multicell Technologies do? Multicell Technologies Inc is a US-American company specialized in the development and production of innovative products in the field of biomedical and biotechnological research. The company was founded in 1987 by a team of scientists and has held a leading position in the industry ever since. They develop technologies for the isolation and artificial reproduction of cell cultures, collaborate with leading scientists and research institutions to develop new methods and products for fighting diseases such as cancer and cardiovascular diseases, and offer a wide range of products for biomedical and biotechnological research, including cell culture systems, antibody products, and specialized analysis tools. They also work on the production of cell lines and cultures and develop active therapeutics, including a program for developing a new therapeutic for multiple sclerosis. Additionally, they have a diagnostics business and have developed a special platform for DNA sequencing. Overall, Multicell Technologies Inc is known for its close collaboration with the scientific community and its dedication to developing innovative products for the medical field. Multicell Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Multicell Technologies stock

Equity Turnover of Multicell Technologies is -0.34 in 2026.

On Eulerpool you can find the complete historical development of Equity Turnover Multicell Technologies since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Multicell Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

Profitability — Multicell Technologies

All Key Metrics — Multicell Technologies